nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ADRA2A—type 2 diabetes mellitus	0.148	0.42	CbGaD
Trazodone—HTR2C—type 2 diabetes mellitus	0.136	0.387	CbGaD
Trazodone—CYP3A4—type 2 diabetes mellitus	0.068	0.193	CbGaD
Trazodone—ORM1—Nateglinide—type 2 diabetes mellitus	0.0388	0.0941	CbGbCtD
Trazodone—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0374	0.0906	CbGbCtD
Trazodone—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0243	0.059	CbGbCtD
Trazodone—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0229	0.0556	CbGbCtD
Trazodone—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0219	0.0532	CbGbCtD
Trazodone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0219	0.0532	CbGbCtD
Trazodone—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.021	0.051	CbGbCtD
Trazodone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0175	0.0424	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0175	0.0424	CbGbCtD
Trazodone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0175	0.0424	CbGbCtD
Trazodone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0156	0.0378	CbGbCtD
Trazodone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0131	0.0318	CbGbCtD
Trazodone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0273	CbGbCtD
Trazodone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0106	0.0257	CbGbCtD
Trazodone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0105	0.0254	CbGbCtD
Trazodone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0098	0.0238	CbGbCtD
Trazodone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00934	0.0226	CbGbCtD
Trazodone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00854	0.0207	CbGbCtD
Trazodone—CYP3A5—Losartan—type 2 diabetes mellitus	0.00811	0.0196	CbGbCtD
Trazodone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00805	0.0195	CbGbCtD
Trazodone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00774	0.0188	CbGbCtD
Trazodone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00771	0.0187	CbGbCtD
Trazodone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00747	0.0181	CbGbCtD
Trazodone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00675	0.0164	CbGbCtD
Trazodone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00577	0.014	CbGbCtD
Trazodone—ABCB1—Losartan—type 2 diabetes mellitus	0.00528	0.0128	CbGbCtD
Trazodone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00512	0.0124	CbGbCtD
Trazodone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00491	0.0119	CbGbCtD
Trazodone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00491	0.0119	CbGbCtD
Trazodone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00464	0.0112	CbGbCtD
Trazodone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00346	0.00838	CbGbCtD
Trazodone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00316	0.00766	CbGbCtD
Trazodone—HTR2A—arteriole—type 2 diabetes mellitus	0.00222	0.125	CbGeAlD
Trazodone—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00142	0.0796	CbGeAlD
Trazodone—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000953	0.0535	CbGeAlD
Trazodone—HTR2A—hindlimb—type 2 diabetes mellitus	0.000881	0.0495	CbGeAlD
Trazodone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000809	0.0454	CbGeAlD
Trazodone—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000688	0.0386	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000623	0.035	CbGeAlD
Trazodone—HTR2A—artery—type 2 diabetes mellitus	0.00054	0.0303	CbGeAlD
Trazodone—HTR2A—nerve—type 2 diabetes mellitus	0.000536	0.0301	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000533	0.0299	CbGeAlD
Trazodone—HTR2A—endothelium—type 2 diabetes mellitus	0.000456	0.0256	CbGeAlD
Trazodone—CYP3A7—liver—type 2 diabetes mellitus	0.000407	0.0229	CbGeAlD
Trazodone—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000352	0.0197	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000346	0.0194	CbGeAlD
Trazodone—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000335	0.0188	CbGeAlD
Trazodone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.00032	0.018	CbGeAlD
Trazodone—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000315	0.0177	CbGeAlD
Trazodone—HTR2B—adipose tissue—type 2 diabetes mellitus	0.00031	0.0174	CbGeAlD
Trazodone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000305	0.0171	CbGeAlD
Trazodone—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00029	0.0163	CbGeAlD
Trazodone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000258	0.0145	CbGeAlD
Trazodone—ORM1—liver—type 2 diabetes mellitus	0.000258	0.0145	CbGeAlD
Trazodone—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000256	0.0144	CbGeAlD
Trazodone—CYP3A5—kidney—type 2 diabetes mellitus	0.000227	0.0127	CbGeAlD
Trazodone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000225	0.0126	CbGeAlD
Trazodone—HTR2A—retina—type 2 diabetes mellitus	0.000222	0.0125	CbGeAlD
Trazodone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000221	0.0124	CbGeAlD
Trazodone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000215	0.0121	CbGeAlD
Trazodone—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000212	0.06	CrCbGaD
Trazodone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.00021	0.0118	CbGeAlD
Trazodone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000204	0.0115	CbGeAlD
Trazodone—HRH1—adipose tissue—type 2 diabetes mellitus	0.000198	0.0111	CbGeAlD
Trazodone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000195	0.0109	CbGeAlD
Trazodone—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000188	0.0105	CbGeAlD
Trazodone—Vilazodone—CYP3A4—type 2 diabetes mellitus	0.000185	0.0523	CrCbGaD
Trazodone—HTR2A—kidney—type 2 diabetes mellitus	0.000184	0.0103	CbGeAlD
Trazodone—ADRA1A—liver—type 2 diabetes mellitus	0.00018	0.0101	CbGeAlD
Trazodone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00017	0.00955	CbGeAlD
Trazodone—CYP3A4—kidney—type 2 diabetes mellitus	0.00017	0.00955	CbGeAlD
Trazodone—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.00017	0.0479	CrCbGaD
Trazodone—Perphenazine—CALM1—type 2 diabetes mellitus	0.000168	0.0474	CrCbGaD
Trazodone—CYP2D6—kidney—type 2 diabetes mellitus	0.000167	0.0094	CbGeAlD
Trazodone—Ziprasidone—ADRA2A—type 2 diabetes mellitus	0.000153	0.0431	CrCbGaD
Trazodone—ABCB1—retina—type 2 diabetes mellitus	0.000145	0.00817	CbGeAlD
Trazodone—CYP3A5—liver—type 2 diabetes mellitus	0.000143	0.00804	CbGeAlD
Trazodone—Ziprasidone—HTR2C—type 2 diabetes mellitus	0.00014	0.0397	CrCbGaD
Trazodone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000137	0.00769	CbGeAlD
Trazodone—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000129	0.0364	CrCbGaD
Trazodone—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.000128	0.0362	CrCbGaD
Trazodone—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000123	0.00691	CbGeAlD
Trazodone—ABCB1—kidney—type 2 diabetes mellitus	0.00012	0.00676	CbGeAlD
Trazodone—ABCB1—pancreas—type 2 diabetes mellitus	0.00012	0.00671	CbGeAlD
Trazodone—Aripiprazole—ADRA2A—type 2 diabetes mellitus	0.000119	0.0337	CrCbGaD
Trazodone—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000118	0.0333	CrCbGaD
Trazodone—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000117	0.00658	CbGeAlD
Trazodone—HTR2A—liver—type 2 diabetes mellitus	0.000116	0.00652	CbGeAlD
Trazodone—Aripiprazole—HTR2C—type 2 diabetes mellitus	0.00011	0.031	CrCbGaD
Trazodone—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000109	0.00609	CbGeAlD
Trazodone—CYP3A4—liver—type 2 diabetes mellitus	0.000107	0.00604	CbGeAlD
Trazodone—Domperidone—CYP1A2—type 2 diabetes mellitus	0.000107	0.0303	CrCbGaD
Trazodone—Ziprasidone—CYP1A2—type 2 diabetes mellitus	0.000106	0.0299	CrCbGaD
Trazodone—CYP2D6—liver—type 2 diabetes mellitus	0.000106	0.00594	CbGeAlD
Trazodone—Prochlorperazine—HTR2C—type 2 diabetes mellitus	9.78e-05	0.0276	CrCbGaD
Trazodone—Fluphenazine—ADRA2A—type 2 diabetes mellitus	9.61e-05	0.0271	CrCbGaD
Trazodone—Fluphenazine—HTR2C—type 2 diabetes mellitus	8.85e-05	0.025	CrCbGaD
Trazodone—Visual impairment—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000542	CcSEcCtD
Trazodone—Discomfort—Metformin—type 2 diabetes mellitus	7.9e-05	0.000541	CcSEcCtD
Trazodone—Fatigue—Gliclazide—type 2 diabetes mellitus	7.9e-05	0.000541	CcSEcCtD
Trazodone—Nausea—Glipizide—type 2 diabetes mellitus	7.88e-05	0.000539	CcSEcCtD
Trazodone—Vomiting—Glimepiride—type 2 diabetes mellitus	7.87e-05	0.000539	CcSEcCtD
Trazodone—Hypotension—Valsartan—type 2 diabetes mellitus	7.87e-05	0.000539	CcSEcCtD
Trazodone—Vision blurred—Losartan—type 2 diabetes mellitus	7.86e-05	0.000538	CcSEcCtD
Trazodone—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.84e-05	0.000537	CcSEcCtD
Trazodone—Constipation—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000537	CcSEcCtD
Trazodone—Pain—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000537	CcSEcCtD
Trazodone—Tremor—Losartan—type 2 diabetes mellitus	7.82e-05	0.000535	CcSEcCtD
Trazodone—Rash—Glimepiride—type 2 diabetes mellitus	7.8e-05	0.000534	CcSEcCtD
Trazodone—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.79e-05	0.000534	CcSEcCtD
Trazodone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000533	CcSEcCtD
Trazodone—Rash—Sitagliptin—type 2 diabetes mellitus	7.78e-05	0.000533	CcSEcCtD
Trazodone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.77e-05	0.000532	CcSEcCtD
Trazodone—Headache—Glimepiride—type 2 diabetes mellitus	7.75e-05	0.000531	CcSEcCtD
Trazodone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.74e-05	0.00053	CcSEcCtD
Trazodone—Headache—Sitagliptin—type 2 diabetes mellitus	7.73e-05	0.000529	CcSEcCtD
Trazodone—Anaemia—Losartan—type 2 diabetes mellitus	7.71e-05	0.000528	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.67e-05	0.000525	CcSEcCtD
Trazodone—Agitation—Losartan—type 2 diabetes mellitus	7.67e-05	0.000525	CcSEcCtD
Trazodone—Oedema—Metformin—type 2 diabetes mellitus	7.67e-05	0.000525	CcSEcCtD
Trazodone—Tinnitus—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000525	CcSEcCtD
Trazodone—Hypertension—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000524	CcSEcCtD
Trazodone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.64e-05	0.000523	CcSEcCtD
Trazodone—Loxapine—ADRA2A—type 2 diabetes mellitus	7.64e-05	0.0216	CrCbGaD
Trazodone—Flushing—Ramipril—type 2 diabetes mellitus	7.63e-05	0.000522	CcSEcCtD
Trazodone—Insomnia—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000521	CcSEcCtD
Trazodone—ABCB1—liver—type 2 diabetes mellitus	7.61e-05	0.00427	CbGeAlD
Trazodone—Perphenazine—ADRA2A—type 2 diabetes mellitus	7.6e-05	0.0215	CrCbGaD
Trazodone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.58e-05	0.000519	CcSEcCtD
Trazodone—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.56e-05	0.000518	CcSEcCtD
Trazodone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.55e-05	0.000517	CcSEcCtD
Trazodone—Myalgia—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000517	CcSEcCtD
Trazodone—Chest pain—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000517	CcSEcCtD
Trazodone—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000517	CcSEcCtD
Trazodone—Shock—Metformin—type 2 diabetes mellitus	7.54e-05	0.000516	CcSEcCtD
Trazodone—Insomnia—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000515	CcSEcCtD
Trazodone—Malaise—Losartan—type 2 diabetes mellitus	7.52e-05	0.000515	CcSEcCtD
Trazodone—Anxiety—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000515	CcSEcCtD
Trazodone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.52e-05	0.000515	CcSEcCtD
Trazodone—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000514	CcSEcCtD
Trazodone—Vertigo—Losartan—type 2 diabetes mellitus	7.5e-05	0.000513	CcSEcCtD
Trazodone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.000513	CcSEcCtD
Trazodone—Somnolence—Valsartan—type 2 diabetes mellitus	7.48e-05	0.000512	CcSEcCtD
Trazodone—Syncope—Losartan—type 2 diabetes mellitus	7.48e-05	0.000512	CcSEcCtD
Trazodone—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.47e-05	0.000511	CcSEcCtD
Trazodone—Discomfort—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000511	CcSEcCtD
Trazodone—Quetiapine—ADRA2A—type 2 diabetes mellitus	7.45e-05	0.021	CrCbGaD
Trazodone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.41e-05	0.000507	CcSEcCtD
Trazodone—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.38e-05	0.000505	CcSEcCtD
Trazodone—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000505	CcSEcCtD
Trazodone—Palpitations—Losartan—type 2 diabetes mellitus	7.37e-05	0.000505	CcSEcCtD
Trazodone—Nausea—Glimepiride—type 2 diabetes mellitus	7.35e-05	0.000503	CcSEcCtD
Trazodone—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000503	CcSEcCtD
Trazodone—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.33e-05	0.000502	CcSEcCtD
Trazodone—Nausea—Sitagliptin—type 2 diabetes mellitus	7.33e-05	0.000502	CcSEcCtD
Trazodone—Asthenia—Glyburide—type 2 diabetes mellitus	7.32e-05	0.000501	CcSEcCtD
Trazodone—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000501	CcSEcCtD
Trazodone—Anorexia—Metformin—type 2 diabetes mellitus	7.31e-05	0.0005	CcSEcCtD
Trazodone—Urticaria—Gliclazide—type 2 diabetes mellitus	7.28e-05	0.000498	CcSEcCtD
Trazodone—Alopecia—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000497	CcSEcCtD
Trazodone—Fatigue—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000497	CcSEcCtD
Trazodone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000496	CcSEcCtD
Trazodone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000496	CcSEcCtD
Trazodone—Oedema—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000495	CcSEcCtD
Trazodone—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000495	CcSEcCtD
Trazodone—Pruritus—Glyburide—type 2 diabetes mellitus	7.22e-05	0.000494	CcSEcCtD
Trazodone—Constipation—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000493	CcSEcCtD
Trazodone—Fatigue—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000491	CcSEcCtD
Trazodone—Hypotension—Metformin—type 2 diabetes mellitus	7.16e-05	0.000491	CcSEcCtD
Trazodone—Shock—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000487	CcSEcCtD
Trazodone—Pain—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000487	CcSEcCtD
Trazodone—Myalgia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000486	CcSEcCtD
Trazodone—Arthralgia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000486	CcSEcCtD
Trazodone—Chest pain—Losartan—type 2 diabetes mellitus	7.1e-05	0.000486	CcSEcCtD
Trazodone—Domperidone—CYP3A4—type 2 diabetes mellitus	7.1e-05	0.0201	CrCbGaD
Trazodone—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.1e-05	0.000486	CcSEcCtD
Trazodone—Anxiety—Losartan—type 2 diabetes mellitus	7.08e-05	0.000485	CcSEcCtD
Trazodone—Trifluoperazine—HTR2C—type 2 diabetes mellitus	7.07e-05	0.02	CrCbGaD
Trazodone—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.000483	CcSEcCtD
Trazodone—Rash—Bromocriptine—type 2 diabetes mellitus	7.04e-05	0.000482	CcSEcCtD
Trazodone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.03e-05	0.000481	CcSEcCtD
Trazodone—Loxapine—HTR2C—type 2 diabetes mellitus	7.03e-05	0.0198	CrCbGaD
Trazodone—Tension—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000481	CcSEcCtD
Trazodone—Fluphenazine—CYP2E1—type 2 diabetes mellitus	7.02e-05	0.0198	CrCbGaD
Trazodone—Ziprasidone—CYP3A4—type 2 diabetes mellitus	7.02e-05	0.0198	CrCbGaD
Trazodone—Discomfort—Losartan—type 2 diabetes mellitus	7.02e-05	0.00048	CcSEcCtD
Trazodone—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.01e-05	0.00048	CcSEcCtD
Trazodone—Perphenazine—HTR2C—type 2 diabetes mellitus	7e-05	0.0198	CrCbGaD
Trazodone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.99e-05	0.000479	CcSEcCtD
Trazodone—Headache—Bromocriptine—type 2 diabetes mellitus	6.99e-05	0.000479	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.98e-05	0.000478	CcSEcCtD
Trazodone—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.98e-05	0.000478	CcSEcCtD
Trazodone—Nervousness—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000476	CcSEcCtD
Trazodone—Dry mouth—Losartan—type 2 diabetes mellitus	6.95e-05	0.000476	CcSEcCtD
Trazodone—Anorexia—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000472	CcSEcCtD
Trazodone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000471	CcSEcCtD
Trazodone—Paraesthesia—Metformin—type 2 diabetes mellitus	6.88e-05	0.000471	CcSEcCtD
Trazodone—Confusional state—Losartan—type 2 diabetes mellitus	6.87e-05	0.00047	CcSEcCtD
Trazodone—Quetiapine—HTR2C—type 2 diabetes mellitus	6.86e-05	0.0194	CrCbGaD
Trazodone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.86e-05	0.000469	CcSEcCtD
Trazodone—Dyspnoea—Metformin—type 2 diabetes mellitus	6.83e-05	0.000468	CcSEcCtD
Trazodone—Somnolence—Metformin—type 2 diabetes mellitus	6.82e-05	0.000467	CcSEcCtD
Trazodone—Oedema—Losartan—type 2 diabetes mellitus	6.81e-05	0.000466	CcSEcCtD
Trazodone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000466	CcSEcCtD
Trazodone—Hypotension—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000463	CcSEcCtD
Trazodone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.75e-05	0.000462	CcSEcCtD
Trazodone—Tremor—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000459	CcSEcCtD
Trazodone—Shock—Losartan—type 2 diabetes mellitus	6.7e-05	0.000459	CcSEcCtD
Trazodone—Urticaria—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000458	CcSEcCtD
Trazodone—Fluphenazine—CYP1A2—type 2 diabetes mellitus	6.68e-05	0.0189	CrCbGaD
Trazodone—Decreased appetite—Metformin—type 2 diabetes mellitus	6.66e-05	0.000456	CcSEcCtD
Trazodone—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000456	CcSEcCtD
Trazodone—Tachycardia—Losartan—type 2 diabetes mellitus	6.65e-05	0.000455	CcSEcCtD
Trazodone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000454	CcSEcCtD
Trazodone—Nausea—Bromocriptine—type 2 diabetes mellitus	6.63e-05	0.000454	CcSEcCtD
Trazodone—Fatigue—Metformin—type 2 diabetes mellitus	6.61e-05	0.000453	CcSEcCtD
Trazodone—Urticaria—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000453	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000451	CcSEcCtD
Trazodone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.58e-05	0.000451	CcSEcCtD
Trazodone—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.58e-05	0.00045	CcSEcCtD
Trazodone—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.58e-05	0.00045	CcSEcCtD
Trazodone—Asthenia—Gliclazide—type 2 diabetes mellitus	6.57e-05	0.00045	CcSEcCtD
Trazodone—Agitation—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00045	CcSEcCtD
Trazodone—Constipation—Metformin—type 2 diabetes mellitus	6.56e-05	0.000449	CcSEcCtD
Trazodone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.000445	CcSEcCtD
Trazodone—Anorexia—Losartan—type 2 diabetes mellitus	6.49e-05	0.000444	CcSEcCtD
Trazodone—Vomiting—Glyburide—type 2 diabetes mellitus	6.49e-05	0.000444	CcSEcCtD
Trazodone—Pruritus—Gliclazide—type 2 diabetes mellitus	6.48e-05	0.000444	CcSEcCtD
Trazodone—Malaise—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000442	CcSEcCtD
Trazodone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000442	CcSEcCtD
Trazodone—Rash—Glyburide—type 2 diabetes mellitus	6.43e-05	0.000441	CcSEcCtD
Trazodone—Somnolence—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.00044	CcSEcCtD
Trazodone—Dermatitis—Glyburide—type 2 diabetes mellitus	6.43e-05	0.00044	CcSEcCtD
Trazodone—Vertigo—Ramipril—type 2 diabetes mellitus	6.43e-05	0.00044	CcSEcCtD
Trazodone—Syncope—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000439	CcSEcCtD
Trazodone—Clozapine—ADRA2A—type 2 diabetes mellitus	6.41e-05	0.0181	CrCbGaD
Trazodone—Headache—Glyburide—type 2 diabetes mellitus	6.39e-05	0.000438	CcSEcCtD
Trazodone—Hypotension—Losartan—type 2 diabetes mellitus	6.36e-05	0.000436	CcSEcCtD
Trazodone—Palpitations—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000433	CcSEcCtD
Trazodone—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.32e-05	0.000433	CcSEcCtD
Trazodone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000431	CcSEcCtD
Trazodone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000431	CcSEcCtD
Trazodone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.27e-05	0.000429	CcSEcCtD
Trazodone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.27e-05	0.000429	CcSEcCtD
Trazodone—Fatigue—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000427	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.2e-05	0.000425	CcSEcCtD
Trazodone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.2e-05	0.000425	CcSEcCtD
Trazodone—Pain—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000424	CcSEcCtD
Trazodone—Constipation—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000424	CcSEcCtD
Trazodone—Insomnia—Losartan—type 2 diabetes mellitus	6.16e-05	0.000422	CcSEcCtD
Trazodone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.13e-05	0.00042	CcSEcCtD
Trazodone—Paraesthesia—Losartan—type 2 diabetes mellitus	6.11e-05	0.000419	CcSEcCtD
Trazodone—Urticaria—Metformin—type 2 diabetes mellitus	6.09e-05	0.000417	CcSEcCtD
Trazodone—Myalgia—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000417	CcSEcCtD
Trazodone—Chest pain—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000417	CcSEcCtD
Trazodone—Arthralgia—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000417	CcSEcCtD
Trazodone—Dyspnoea—Losartan—type 2 diabetes mellitus	6.07e-05	0.000416	CcSEcCtD
Trazodone—Anxiety—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000416	CcSEcCtD
Trazodone—Nausea—Glyburide—type 2 diabetes mellitus	6.06e-05	0.000415	CcSEcCtD
Trazodone—Abdominal pain—Metformin—type 2 diabetes mellitus	6.06e-05	0.000415	CcSEcCtD
Trazodone—Dizziness—Gliclazide—type 2 diabetes mellitus	6.06e-05	0.000415	CcSEcCtD
Trazodone—Somnolence—Losartan—type 2 diabetes mellitus	6.05e-05	0.000414	CcSEcCtD
Trazodone—Asthenia—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000414	CcSEcCtD
Trazodone—Discomfort—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000412	CcSEcCtD
Trazodone—Asthenia—Orlistat—type 2 diabetes mellitus	5.97e-05	0.000409	CcSEcCtD
Trazodone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000408	CcSEcCtD
Trazodone—Pruritus—Valsartan—type 2 diabetes mellitus	5.96e-05	0.000408	CcSEcCtD
Trazodone—Dry mouth—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000408	CcSEcCtD
Trazodone—Decreased appetite—Losartan—type 2 diabetes mellitus	5.92e-05	0.000405	CcSEcCtD
Trazodone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000405	CcSEcCtD
Trazodone—Clozapine—HTR2C—type 2 diabetes mellitus	5.9e-05	0.0167	CrCbGaD
Trazodone—Nefazodone—CYP3A4—type 2 diabetes mellitus	5.9e-05	0.0167	CrCbGaD
Trazodone—Confusional state—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000403	CcSEcCtD
Trazodone—Pruritus—Orlistat—type 2 diabetes mellitus	5.89e-05	0.000403	CcSEcCtD
Trazodone—Fatigue—Losartan—type 2 diabetes mellitus	5.87e-05	0.000402	CcSEcCtD
Trazodone—Oedema—Ramipril—type 2 diabetes mellitus	5.84e-05	0.0004	CcSEcCtD
Trazodone—Vomiting—Gliclazide—type 2 diabetes mellitus	5.83e-05	0.000399	CcSEcCtD
Trazodone—Constipation—Losartan—type 2 diabetes mellitus	5.82e-05	0.000399	CcSEcCtD
Trazodone—Pain—Losartan—type 2 diabetes mellitus	5.82e-05	0.000399	CcSEcCtD
Trazodone—Rash—Gliclazide—type 2 diabetes mellitus	5.78e-05	0.000396	CcSEcCtD
Trazodone—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000395	CcSEcCtD
Trazodone—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.76e-05	0.000394	CcSEcCtD
Trazodone—Urticaria—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000394	CcSEcCtD
Trazodone—Shock—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000393	CcSEcCtD
Trazodone—Headache—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000393	CcSEcCtD
Trazodone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000392	CcSEcCtD
Trazodone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000392	CcSEcCtD
Trazodone—Tachycardia—Ramipril—type 2 diabetes mellitus	5.7e-05	0.00039	CcSEcCtD
Trazodone—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.69e-05	0.00039	CcSEcCtD
Trazodone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000386	CcSEcCtD
Trazodone—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.61e-05	0.000384	CcSEcCtD
Trazodone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.57e-05	0.000381	CcSEcCtD
Trazodone—Dizziness—Valsartan—type 2 diabetes mellitus	5.57e-05	0.000381	CcSEcCtD
Trazodone—Anorexia—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000381	CcSEcCtD
Trazodone—Dizziness—Orlistat—type 2 diabetes mellitus	5.5e-05	0.000377	CcSEcCtD
Trazodone—Asthenia—Metformin—type 2 diabetes mellitus	5.5e-05	0.000377	CcSEcCtD
Trazodone—Aripiprazole—CYP3A4—type 2 diabetes mellitus	5.48e-05	0.0155	CrCbGaD
Trazodone—Hypotension—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000374	CcSEcCtD
Trazodone—Nausea—Gliclazide—type 2 diabetes mellitus	5.44e-05	0.000373	CcSEcCtD
Trazodone—Pruritus—Metformin—type 2 diabetes mellitus	5.42e-05	0.000371	CcSEcCtD
Trazodone—Urticaria—Losartan—type 2 diabetes mellitus	5.41e-05	0.00037	CcSEcCtD
Trazodone—Body temperature increased—Losartan—type 2 diabetes mellitus	5.38e-05	0.000369	CcSEcCtD
Trazodone—Abdominal pain—Losartan—type 2 diabetes mellitus	5.38e-05	0.000369	CcSEcCtD
Trazodone—Vomiting—Valsartan—type 2 diabetes mellitus	5.35e-05	0.000367	CcSEcCtD
Trazodone—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	5.34e-05	0.0151	CrCbGaD
Trazodone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000365	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000364	CcSEcCtD
Trazodone—Rash—Valsartan—type 2 diabetes mellitus	5.31e-05	0.000363	CcSEcCtD
Trazodone—Dermatitis—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000363	CcSEcCtD
Trazodone—Vomiting—Orlistat—type 2 diabetes mellitus	5.29e-05	0.000362	CcSEcCtD
Trazodone—Insomnia—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000362	CcSEcCtD
Trazodone—Perphenazine—CYP1A2—type 2 diabetes mellitus	5.28e-05	0.0149	CrCbGaD
Trazodone—Headache—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000361	CcSEcCtD
Trazodone—Diarrhoea—Metformin—type 2 diabetes mellitus	5.25e-05	0.000359	CcSEcCtD
Trazodone—Rash—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000359	CcSEcCtD
Trazodone—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000359	CcSEcCtD
Trazodone—Dermatitis—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000359	CcSEcCtD
Trazodone—Headache—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000357	CcSEcCtD
Trazodone—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000356	CcSEcCtD
Trazodone—Asthenia—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000355	CcSEcCtD
Trazodone—Somnolence—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000355	CcSEcCtD
Trazodone—Pruritus—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.00035	CcSEcCtD
Trazodone—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000348	CcSEcCtD
Trazodone—Dizziness—Metformin—type 2 diabetes mellitus	5.07e-05	0.000347	CcSEcCtD
Trazodone—Fatigue—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000345	CcSEcCtD
Trazodone—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.02e-05	0.000343	CcSEcCtD
Trazodone—Nausea—Valsartan—type 2 diabetes mellitus	5e-05	0.000342	CcSEcCtD
Trazodone—Constipation—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000342	CcSEcCtD
Trazodone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000339	CcSEcCtD
Trazodone—Nausea—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000338	CcSEcCtD
Trazodone—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	4.89e-05	0.0138	CrCbGaD
Trazodone—Asthenia—Losartan—type 2 diabetes mellitus	4.89e-05	0.000334	CcSEcCtD
Trazodone—Vomiting—Metformin—type 2 diabetes mellitus	4.87e-05	0.000334	CcSEcCtD
Trazodone—Rash—Metformin—type 2 diabetes mellitus	4.83e-05	0.000331	CcSEcCtD
Trazodone—Dermatitis—Metformin—type 2 diabetes mellitus	4.83e-05	0.000331	CcSEcCtD
Trazodone—Pruritus—Losartan—type 2 diabetes mellitus	4.82e-05	0.00033	CcSEcCtD
Trazodone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000329	CcSEcCtD
Trazodone—Headache—Metformin—type 2 diabetes mellitus	4.8e-05	0.000329	CcSEcCtD
Trazodone—Dizziness—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000328	CcSEcCtD
Trazodone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000327	CcSEcCtD
Trazodone—Clozapine—CYP2E1—type 2 diabetes mellitus	4.68e-05	0.0132	CrCbGaD
Trazodone—Diarrhoea—Losartan—type 2 diabetes mellitus	4.66e-05	0.000319	CcSEcCtD
Trazodone—Urticaria—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000318	CcSEcCtD
Trazodone—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000316	CcSEcCtD
Trazodone—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000316	CcSEcCtD
Trazodone—Vomiting—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000315	CcSEcCtD
Trazodone—Rash—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000312	CcSEcCtD
Trazodone—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000312	CcSEcCtD
Trazodone—Nausea—Metformin—type 2 diabetes mellitus	4.55e-05	0.000312	CcSEcCtD
Trazodone—Thioproperazine—ALB—type 2 diabetes mellitus	4.53e-05	0.0128	CrCbGaD
Trazodone—Headache—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.00031	CcSEcCtD
Trazodone—Dizziness—Losartan—type 2 diabetes mellitus	4.5e-05	0.000308	CcSEcCtD
Trazodone—Clozapine—CYP1A2—type 2 diabetes mellitus	4.45e-05	0.0126	CrCbGaD
Trazodone—Vomiting—Losartan—type 2 diabetes mellitus	4.33e-05	0.000296	CcSEcCtD
Trazodone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000295	CcSEcCtD
Trazodone—Nausea—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000294	CcSEcCtD
Trazodone—Rash—Losartan—type 2 diabetes mellitus	4.29e-05	0.000294	CcSEcCtD
Trazodone—Dermatitis—Losartan—type 2 diabetes mellitus	4.29e-05	0.000294	CcSEcCtD
Trazodone—Headache—Losartan—type 2 diabetes mellitus	4.27e-05	0.000292	CcSEcCtD
Trazodone—Asthenia—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000287	CcSEcCtD
Trazodone—Pruritus—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000283	CcSEcCtD
Trazodone—Nausea—Losartan—type 2 diabetes mellitus	4.04e-05	0.000277	CcSEcCtD
Trazodone—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000274	CcSEcCtD
Trazodone—Dizziness—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000264	CcSEcCtD
Trazodone—Vomiting—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000254	CcSEcCtD
Trazodone—Rash—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000252	CcSEcCtD
Trazodone—Dermatitis—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000252	CcSEcCtD
Trazodone—Headache—Ramipril—type 2 diabetes mellitus	3.66e-05	0.00025	CcSEcCtD
Trazodone—Perphenazine—CYP3A4—type 2 diabetes mellitus	3.5e-05	0.00987	CrCbGaD
Trazodone—Nausea—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000237	CcSEcCtD
Trazodone—Quetiapine—CYP3A4—type 2 diabetes mellitus	3.43e-05	0.00968	CrCbGaD
Trazodone—Clozapine—CYP3A4—type 2 diabetes mellitus	2.95e-05	0.00832	CrCbGaD
Trazodone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.86e-06	4.19e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	2.85e-06	4.19e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.85e-06	4.18e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.84e-06	4.18e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.84e-06	4.17e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.83e-06	4.16e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.83e-06	4.15e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.8e-06	4.12e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.8e-06	4.11e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.8e-06	4.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.8e-06	4.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	2.8e-06	4.11e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.8e-06	4.1e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.8e-06	4.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.79e-06	4.1e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.78e-06	4.09e-05	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	2.78e-06	4.08e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.78e-06	4.08e-05	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.76e-06	4.05e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	4.04e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.75e-06	4.03e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.75e-06	4.03e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.74e-06	4.03e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.74e-06	4.02e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.74e-06	4.02e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.73e-06	4.01e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.73e-06	4.01e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.73e-06	4e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.73e-06	4e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.73e-06	4e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.72e-06	3.99e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.71e-06	3.99e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.71e-06	3.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.71e-06	3.97e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	3.97e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.68e-06	3.94e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.68e-06	3.93e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.67e-06	3.91e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.66e-06	3.91e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	3.88e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	3.87e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.63e-06	3.86e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.63e-06	3.86e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.61e-06	3.84e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.61e-06	3.83e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.61e-06	3.83e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.6e-06	3.81e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.6e-06	3.81e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.59e-06	3.81e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.58e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.57e-06	3.77e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.57e-06	3.77e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.57e-06	3.77e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	2.56e-06	3.76e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.56e-06	3.76e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.55e-06	3.75e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.55e-06	3.74e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	3.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.53e-06	3.71e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.52e-06	3.71e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.52e-06	3.7e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.5e-06	3.68e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.49e-06	3.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.49e-06	3.65e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.49e-06	3.65e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.48e-06	3.65e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.48e-06	3.64e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.48e-06	3.64e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.48e-06	3.64e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.47e-06	3.63e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.47e-06	3.62e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.46e-06	3.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	2.45e-06	3.6e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	2.45e-06	3.6e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.45e-06	3.59e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.45e-06	3.59e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.45e-06	3.59e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.44e-06	3.59e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.44e-06	3.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.44e-06	3.57e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.43e-06	3.57e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	3.57e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.42e-06	3.56e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.42e-06	3.55e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.4e-06	3.52e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.39e-06	3.51e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	3.5e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.38e-06	3.49e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.38e-06	3.49e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.36e-06	3.47e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.36e-06	3.46e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	3.45e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.34e-06	3.43e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.33e-06	3.42e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.32e-06	3.4e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.31e-06	3.39e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	3.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.3e-06	3.38e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.29e-06	3.36e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	3.34e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.25e-06	3.31e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.25e-06	3.31e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	3.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	2.24e-06	3.29e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	3.29e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.24e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.24e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.22e-06	3.27e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.22e-06	3.25e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.21e-06	3.25e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.21e-06	3.25e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.21e-06	3.24e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.21e-06	3.24e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.2e-06	3.24e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.2e-06	3.23e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.19e-06	3.22e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.18e-06	3.2e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.15e-06	3.15e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.14e-06	3.14e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.13e-06	3.13e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.13e-06	3.12e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.12e-06	3.12e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.12e-06	3.11e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.12e-06	3.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.12e-06	3.11e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.11e-06	3.1e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.09e-06	3.07e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.09e-06	3.06e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.08e-06	3.06e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.08e-06	3.05e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.07e-06	3.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.06e-06	3.03e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	3.02e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.05e-06	3.01e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.05e-06	3.01e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.03e-06	2.98e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.02e-06	2.97e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	2.9e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	2.84e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.93e-06	2.84e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.93e-06	2.83e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.92e-06	2.82e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.91e-06	2.81e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.91e-06	2.8e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.9e-06	2.79e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.9e-06	2.79e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.89e-06	2.78e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.88e-06	2.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.87e-06	2.75e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.87e-06	2.75e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.86e-06	2.73e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.86e-06	2.73e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.83e-06	2.68e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.83e-06	2.68e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.82e-06	2.68e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.82e-06	2.67e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.81e-06	2.66e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.81e-06	2.65e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.8e-06	2.64e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.79e-06	2.63e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.79e-06	2.62e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	2.6e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.77e-06	2.6e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.76e-06	2.58e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.75e-06	2.58e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.75e-06	2.57e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.75e-06	2.57e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.74e-06	2.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.74e-06	2.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.73e-06	2.54e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.73e-06	2.53e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.72e-06	2.52e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.72e-06	2.52e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	2.49e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	2.49e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.7e-06	2.49e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.69e-06	2.48e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.68e-06	2.47e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.67e-06	2.45e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.67e-06	2.45e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.66e-06	2.44e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.66e-06	2.44e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.65e-06	2.42e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.63e-06	2.4e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.63e-06	2.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.63e-06	2.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.62e-06	2.38e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.62e-06	2.38e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.62e-06	2.38e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.6e-06	2.35e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.6e-06	2.35e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.6e-06	2.35e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.6e-06	2.34e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.59e-06	2.33e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.58e-06	2.32e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.56e-06	2.29e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	2.28e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.52e-06	2.23e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.5e-06	2.2e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.49e-06	2.19e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.49e-06	2.18e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.48e-06	2.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.48e-06	2.17e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.47e-06	2.16e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.46e-06	2.15e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.46e-06	2.15e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-06	2.14e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.46e-06	2.14e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-06	2.1e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	2.1e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.42e-06	2.09e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.4e-06	2.06e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	2.05e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.38e-06	2.02e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.36e-06	1.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.33e-06	1.95e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.3e-06	1.91e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.29e-06	1.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	1.78e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.2e-06	1.76e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.19e-06	1.75e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.19e-06	1.75e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.13e-06	1.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	1.65e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	1.65e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-06	1.61e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.09e-06	1.6e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	1.53e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	1.53e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.52e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.03e-06	1.52e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	1.52e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.02e-06	1.5e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.01e-06	1.49e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.56e-07	1.4e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.43e-07	1.38e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	7.8e-07	1.14e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.35e-07	1.08e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.8e-07	7.05e-06	CbGpPWpGaD
